KRAS and pancreatic neoplasm: In fact, our data confirmed that the chimeric RC‐ODC fusion protein molecule downregulated the level of the KRAS oncoprotein after co‐transfection with AZ and inhibited the growth of the pancreatic cancer cell line PANC‐1 in vitro and in vivo.